Skip to main content

Risk and Medical Decision Making

  • Book
  • © 2002

Overview

Part of the book series: Studies in Risk and Uncertainty (SIRU, volume 14)

  • 1248 Accesses

  • 31 Citations

This is a preview of subscription content, log in via an institution to check access.

Access this book

Softcover Book EUR 106.99
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book EUR 106.99
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

About this book

For people interested in risk management, medical activity represents a stimulating field of study and thought. On the one hand, progress in medical knowledge and technology tends to reduce the risks to survival that individuals would face in the absence of appropriate diagnostic or therapeutic instruments. On the other hand, new medical technologies simultaneously create their own specific risks, sometimes simply because their effects are less well-known than those of established ones. In a sense any medical progress simultaneously generates new risks while destroying old ones. Moreover, unlike many financial risks that can be either divided or transferred to others (e.g. through diversification, insurance or social security) the personal aspects of medical risks are by essence indivisible and non-transferable. As a result, they are in a sense more threatening than financial risks for risk averse patients. These two facts explain and justify the growing interest in risk economics for the fields of medical decision making and health economics.

In Risk and Medical Decision Making, part 1 is developed inside the expected utility (E-U) model and analyses how comorbidity risks affect the well-known "test-treatment" thresholds. Part 2 is devoted to a specific non E-U model with the same purpose: how would one define a threshold in this context and how would one value a diagnostic test? In each of these two parts both diagnostic and therapeutic risks are considered.

Similar content being viewed by others

Table of contents (10 chapters)

  1. Introduction

  2. M.D.M and New Models of Choice Under Risk

Authors and Affiliations

  • Catholic Faculties of Mons (B), Mons, Belgium

    Louis Eeckhoudt

  • Catholic Faculties of Lille (F), Lille, France

    Louis Eeckhoudt

  • Center for Operations Research and Econometrics (CORE), Louvain (B), Belgium

    Louis Eeckhoudt

Accessibility Information

PDF accessibility summary

This PDF is not accessible. It is based on scanned pages and does not support features such as screen reader compatibility or described non-text content (images, graphs etc). However, it likely supports searchable and selectable text based on OCR (Optical Character Recognition). Users with accessibility needs may not be able to use this content effectively. Please contact us at accessibilitysupport@springernature.com if you require assistance or an alternative format.

Bibliographic Information

  • Book Title: Risk and Medical Decision Making

  • Authors: Louis Eeckhoudt

  • Series Title: Studies in Risk and Uncertainty

  • DOI: https://doi.org/10.1007/978-1-4615-0991-2

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 2002

  • Hardcover ISBN: 978-1-4020-7007-5Published: 30 April 2002

  • Softcover ISBN: 978-1-4613-5340-9Published: 01 November 2012

  • eBook ISBN: 978-1-4615-0991-2Published: 06 December 2012

  • Series ISSN: 0926-972X

  • Edition Number: 1

  • Number of Pages: V, 135

  • Topics: Finance, general, Business and Management, general, Microeconomics

Keywords

Publish with us